[Role of the ATM gene in genetic predisposition to cancer].
Bay
J O
JO
Laboratoire d'oncologie moléculaire Inserm CRI 9502 & EA 2145, Centre Jean-Perrin, BP 392, 63011 Clermont-Ferrand Cedex 01.
Uhrhammer
N
N
Stoppa-Lyonnet
D
D
Hall
J
J
D017209:Apoptosis; D001260:Ataxia Telangiectasia / Q000453:epidemiology / Q000235:genetics*; D064007:Ataxia Telangiectasia Mutated Proteins; D001943:Breast Neoplasms / Q000235:genetics*; D018797:Cell Cycle Proteins; D002869:Chromosome Aberrations; D004268:DNA-Binding Proteins; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D008297:Male; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics / Q000502:physiology*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000502:physiology*; D025521:Tumor Suppressor Proteins
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D025521:Tumor Suppressor Proteins; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases